Urschel J D, Finley R K, Takita H
Department of Thoracic Surgery and Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263-0001, USA.
Chest. 1997 Sep;112(3):848-50. doi: 10.1378/chest.112.3.848.
Selected patients with solitary metastases from non-small cell lung cancer can benefit from an aggressive treatment approach that includes resection of the metastases. This approach has been used for solitary adrenal metastases, but successful long-term treatment of bilateral adrenal metastases has not been previously reported. This is the report of a patient with bilateral adrenal metastases from lung cancer who is disease-free 9 years after bilateral adrenalectomy and chemotherapy. From this evidence, one may hypothesize that adrenal metastases are occasionally lymphatic in origin and that metastases with this route of spread are more amenable to aggressive curative treatment than adrenal metastases of hematogenous origin.
部分非小细胞肺癌孤立性转移患者可从包括转移灶切除在内的积极治疗方法中获益。这种方法已用于孤立性肾上腺转移,但双侧肾上腺转移的长期成功治疗此前尚无报道。本文报告了一例肺癌双侧肾上腺转移患者,在双侧肾上腺切除及化疗后9年无疾病复发。据此证据,有人可能推测肾上腺转移瘤偶尔起源于淋巴系统,且通过这种传播途径的转移瘤比血源性肾上腺转移瘤更适合积极的根治性治疗。